Evidence is reviewed for the efficacy of behavioral treatments for hypertension. The format chosen here is a review of reviews given that numerous consensus committee reports and quantitative reviews on the topic have been published. Extensive evidence from over 100 randomized controlled trials indicates that behavioral treatments reduce blood pressure (BP) to a modest degree, and this change is greater than what is seen in wait-list or other inactive controls. Effect sizes are quite variable. The observed BP reductions are much greater when BP levels were high at pre-test, and behavioral studies tend to underestimate possible benefits because of floor effects in their protocols. Blood pressure measured in the office may be confounded with measurement habituation. Multi-component, individualized psychological treatments lead to greater BP changes than do single-component treatments. Among biofeedback treatments, thermal feedback and electrodermal activity feedback fare better than EMG or direct BP feedback, which tend to produce null effects. There continues to be a scarcity of strong protocols that properly control for floor effects and potential measurement confounds.
Similar content being viewed by others
Abbreviations
- BP:
-
blood pressure
- SBP:
-
systolic blood pressure
- DBP:
-
diastolic blood pressure
- ABPM:
-
Ambulatory blood pressure measurement
- ES:
-
(effect size d)
References
Alexander, C. N., Chandler, H. M., Langer, E. J., Newman, R. I., & Davies, J. L. (1989). Transcendental meditation, mindfulness and longevity: An experimental study with the elderly. Journal of Personality and Social Psychology, 37, 930–964.
Concato, J., Shah, N., & Horwittz, R. I. (2000). Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine, 324, 1887–1892.
Davidson, K., MacGregor, M. W., Stuhr, J., & Gidron, Y. (1999). Constructive anger verbal behavior decreases resting blood pressure: A secondary analysis of a randomized controlled hostility intervention. International Journal of Behavioral Medicine, 6, 268–278.
Devine, E. C., & Reifschneider, E. (1995). A meta-analysis of the effects of psycho-educational care in adults with hypertension. Nursing Research, 44, 237–245.
Eisenberg, D. M., Delbanco, T. L., Berkey, C. S., Kaptchuk, T. J., Kupelnick, B., Kuhl, J., et al. (1993). Cognitive behavioral techniques for hypertension: Are they effective? Annals of Internal Medicine, 118, 964–972.
Gerin, W., Pickering, T. G., Glynn, L., Christenfeld, N., Schwartz, A., Carroll, D., et al. (2000). A historical context for behavioral models of hypertension. Journal of Psychosomatic Research, 48, 369–378.
Grossman, P., Watkins, L. L., Wilhelm, F. H., Maolakis, D., & Lown, B. (1996). Cardiac vagal control and dynamic responses to psychological stressors among coronary artery disease patients. American Journal of Cardiology, 78, 1424–1427.
Jacob, R. G., Chesney, M. A., Williams, D. M., Ding, Y., & Shapiro, A. P. (1991). Relaxation therapy for hyper-tension: Design effects and treatment effects. Annals of Behavioral Medicine, 13, 5–17.
JNC VII. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The Journal of the American Medical Association, 289, 2560–2571.
Kaplan, N. M. (1990). Clinical hypertension. Baltimore: Williams & Wilkins.
Kaufmann, P. G., Jacob, R. G., Ewart, C. K., Chesney, M. A., Muenz, L. R., Doub, N., et al. (1988). Hypertension intervention pooling project. Health Psychology, 7(Suppl), 209–224.
Kawachi, I., & Malcolm, L. A. (1991). The cost-effectiveness of treating mild-to-moderate hypertension: A reappraisal. Journal of Hypertension, 9, 199–208.
Kostis, J. B., Rosen, R. C., Brondolo, E., Taska, L., Smith, D. E., & Wilson, A. C. (1992). Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: A randomized, prospective trial. American Heart Journal, 123, 466–474.
LaVaque, T., Hammond, D., Trudeau, D., Monastra, V., Perry, J., Lehrer, P., et al. (2002). Template for developing guidelines for the evaluation of the clinical efficacy of psychophysiological evaluations. Applied Psychophysiology and Biofeedback, 27, 273–281.
Linden, W. (Ed.) (1988). Self-regulation theory in behavioral medicine. In Linden, W. (Ed.). Biological barriers in behavioral medicine (pp. 1–12). New York: Plenum.
Linden, W. (2003). Psychological treatment can be an effective treatment for hypertension. Preventive Cardiology, 6, 48–53.
Linden, W. (2004). Stress management: From basic science to better practice. Thousand Oaks, USA: Sage.
Linden, W., Lenz, J. W., & Con, A. H. (2001). Individualized stress management for primary hypertension: A controlled trial. Archives of Internal Medicine, 161, 1071–1080.
Linden, W., & Chambers, L. A. (1994). Clinical effectiveness of non-drug therapies for hypertension: A meta-analysis. Annals of Behavioral Medicine, 16, 35–45.
Liu, J. E., Roman, M. J., Pini, R., Schwartz, J. E., Pickering, T. G., & Devereux, R. B. (1999). Elevated ambulatory with normal clinic blood pressure (“white coat normotension”) is associated with cardiac and arterial target organ damage. Annals of Internal Medicine, 131, 564–572.
McGrady, A., & Linden, W. (2003). Hypertension. In M. S. Schwartz, & F. Andrasik (Eds.), Biofeedback: A practitioner's handbook (pp. 382–408). New York: Guilford Press.
National High Blood Pressure Education Program Working Group. (1990). Report on ambulatory blood pressure monitoring (NIH Publication No. 90-3028). Washington, DC.
Nakao, M., Yano, E., Nomura, S., & Kuboki, T. (2003). Blood pressure lowering effects of biofeedback treatment in hypertension: A meta-analysis of randomized controlled trials. Hypertension Research, 26, 37–46.
Ong, L., Linden, W., & Young, S. B. (2004) Stress management: What is it? Journal of Psychosomatic Research, 56, 133–137.
Parati, G., Pomidossi, G., Albini, F., Malaspina, D., & Mancia, G. (1987). Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. Journal of Hypertension, 5, 93–98.
Perloff, D., Sokolow, M., Cowan, R. M., & Juster, R. P. (1989). Prognostic value of ambulatory blood pressure measurements: Further analyses. Journal of Hypertension, 7, S3–S10.
Perloff, D., Sokolow, M., & Cowan, R. (1983). The prognostic value of ambulatory blood pressures. The Journal of the American Medical Association, 249, 2792–2798.
Pickering, T. G., James, G. D., Boddie, C., Harshfield, G. A., Blank, S., & Laragh, J. H. (1988). How common is White Coat Hypertension? The Journal of the American Medical Association, 259, 225–228.
Sakakibara, M., & Hayano, J. (1996). Effect of slowed respiration on cardiac parasympathetic response to threat. Psychosomatic Medicine, 58, 32–37.
Sakakibara, M., Takeuchi, S., & Hayano, J. (1994). Effect of relaxation training on cardiac sympathetic tone. Psychophysiology, 31, 223–228.
Selenta, C., Hogan, B., & Linden, W. (2000). How often do office blood pressure measurements fail to identify true hypertension? Archives of Family Medicine, 9, 533–540.
Shapiro, D., Hui, K. K., Oakley, M. E., Pasic, J., & Jamner, L. D. (1997). Reduction in drug requirements by means of a cognitive-behavioral intervention. American Journal of Hypertension, 10, 9–17.
Spence, J. D., Barnett, P. A., Linden, W., Ramsden, V., & Taenzer, P. (1999). Recommendations on stress management. Canadian Medical Association Journal, 160, S46–S50.
The Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure. (1990). Recommendations of the Canadian Consensus Conference on non-pharmacological approaches to the management of high blood pressure. Canadian Medical Association Journal, 42, 1397–1409.
The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1988). The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine, 148, 1023–1038.
Thuermer, H. L., Lund-Larsen, P. G., & Tverdal, A. (1994). Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. Journal of Hypertension, 12, 481–490.
Tomiak, M., & Gentleman, J. F. (1993). Risk factors for hypertension as measured by the Canada Health Survey. Health Reports, 5, 419–430.
Ward, M. M., Swan, G. E., & Chesney, M. A. (1987). Arousal reduction treatments for mild hypertension: A meta-analysis of recent studies. In S. Julius & D. R. Bassett (Eds.), Behavioral factors in hypertension (pp. 285–302). North Holland: Elsevier.
Yucha, C. B., Clark, L., Smith, M., Uris, P., LaFleur, B., & Duval, S. (2001). The effects of biofeedback on hypertension. Applied Nursing Research, 14, 29–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Linden, W., Moseley, J.V. The Efficacy of Behavioral Treatments for Hypertension. Appl Psychophysiol Biofeedback 31, 51–63 (2006). https://doi.org/10.1007/s10484-006-9004-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10484-006-9004-8